MetaCap

ADARx Pharmaceuticals (ADRX) vs Tyra Biosciences (TYRA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

ADARx Pharmaceuticals is the larger company by market cap ($1.42 billion vs $1.39 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ADRX-33.90%TYRA-7.54%
+9%-14%-36%
Sep 25, 20261 yearNov 20, 2026
ADRX-33.90%TYRA-7.54%
+2%-17%-36%
Sep 21, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ADRX versus TYRA key metrics
MetricADRXTYRA
Share price$12.79$20.12
Market cap$1.42B$1.39B
1-day change-9.68%+1.98%
YTD return—-23.47%
1-year return—-4.73%
5-year return—-15.71%
EPS (TTM)$-6.75$-2.63
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)—$-119.95M
52-week high$23.21$40.65
52-week low$12.50$18.25
Distance from 52-week high-44.89%-50.50%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+167.79%+135.83%
Average volume650.63K852.56K
Shares outstanding111.19M69.08M
Employees10087
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About ADARx Pharmaceuticals

ADRX stock →

ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees

About Tyra Biosciences

TYRA stock →

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions.

Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees

ADRX vs TYRA FAQ

Which is bigger, ADARx Pharmaceuticals or Tyra Biosciences?

ADARx Pharmaceuticals (ADRX) is larger, with a market capitalization of $1.42B compared with $1.39B for Tyra Biosciences (TYRA).

Are ADARx Pharmaceuticals and Tyra Biosciences in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons